{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910967117803321"]
[null,null,"Autore",null,"Sands Peter"]
[null,null,"Titolo",null,"Countering the Pandemic Threat Through Global Coordination on Vaccines : The Influenza Imperative"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C. : , : National Academies Press, , 2021"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"0-309-08882-8"]
[{"$nulls":4},"0-309-08876-3"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (237 pages)"]
[null,null,"Disciplina",null,"616.203"]
[null,null,"Soggetti",null,"Influenza"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- FrontMatter -- Reviewers -- National Academy of Medicine: Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response Series -- Acknowledgments -- Preface -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction: The Imperative for Global Investment in Influenza Vaccines -- 2 The Existing Global Governance Landscape for Influenza Vaccines -- 3 Pathogen Sharing for Influenza Vaccine Production -- 4 Technology and Manufacturing Partnerships -- 5 Influenza Vaccine Access and Financing -- 6 Recommendations and the Path Forward -- Appendix A: Committee and Staff Biographies -- Appendix B: Committee Meeting Agendas."]
[null,null,null,"Sommario/riassunto","Introduction : the imperative for global investment in influenza vaccines -- The existing global governance landscape for influenza vaccines -- Pathogen sharing for influenza vaccine production -- Technology and manufacturing partnerships -- Influenza vaccine access and financing -- Recommendations and the path forward."]